XML 38 R28.htm IDEA: XBRL DOCUMENT

CASH AND MARKETABLE SECURITIES (Tables)

6 Months Ended

Jun. 30, 2024

Cash and Cash Equivalents [Abstract]

Summary of Reconciliation of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	June 30, 2024		June 30, 2023
Cash and cash equivalents	$	95,782	$	87,786
Restricted cash	588		584
Total cash, cash equivalents and restricted cash at the end of the period	$	96,370	$	88,370

Summary of Marketable Securities

The amortized cost, gross unrealized holding gains and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	June 30, 2024
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
U.S. agency securities	$	90,403	$	1,268	$	91,671
Corporate debt securities	42,686		365		43,051
Total short-term marketable securities	$	133,089	$	1,633	$	134,722


	December 31, 2023
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
U.S. agency securities	$	80,468	$	2,038	$	82,506
Corporate debt securities	72,753		711		73,464
Total short-term marketable securities	$	153,221	$	2,749	$	155,970